Page 1,897«..1020..1,8961,8971,8981,899..1,9101,920..»

Explore bioinformatics market expects North America to be key future growth driver till 2022 – WhaTech

Posted: Published on March 17th, 2017

Bioinformatics can be described as a field which develops various protocols and software tools to make sense of or glean insights from biological data. Bioinformatics tools utilize the relevant aspects of fields like computer science, engineering,., to break down and make sense of biological information. Various offshoots of bioinformatics research, like computational biology, have gained a very positive following and are being increasingly used in various branches of biology. The future of bioinformatics programs seems to be heading toward the integration and maintenance of bioinformatics databases with the development and discovery of next generation drugs. Scope & Regional Forecast of the Bioinformatics Market The Bioinformatics Market considers the prime growth drivers to be a few factors like: extensive usage of bioinformatics analysis in understanding genomic patterns contained within DNA; usage of bioinformatics technology to analyze and breakdown the structure of various proteins; bioinformatics companies being able to gradually integrate their services into the healthcare infrastructure; improvements being made to bioinformatics research as a result of innovations in data analytics as well as cloud computing. The Bioinformatics Market revenue is expected to cross the $16 billion mark in 2022 and will also be accompanied by a CAGR of 20.83%. The sectors … Continue reading

Posted in BioInformatics | Comments Off on Explore bioinformatics market expects North America to be key future growth driver till 2022 – WhaTech

Bioengineering to Restore Sight – Technology Networks

Posted: Published on March 17th, 2017

Scanning electron micrograph (SEM) image of individual nanowires and groups of nanowires. Each wire can produce an electric current when hit by light. A team of engineers at the University of California San Diego and La Jolla-based startup Nanovision Biosciences Inc. have developed the nanotechnology and wireless electronics for a new type of retinal prosthesis that brings research a step closer to restoring the ability of neurons in the retina to respond to light. The researchers demonstrated this response to light in a rat retina interfacing with a prototype of the device in vitro. They detail their work in a recent issue of the Journal of Neural Engineering. The technology could help tens of millions of people worldwide suffering from neurodegenerative diseases that affect eyesight, including macular degeneration, retinitis pigmentosa and loss of vision due to diabetes. Despite tremendous advances in the development of retinal prostheses over the past two decades, the performance of devices currently on the market to help the blind regain functional vision is still severely limited -well under the acuity threshold of 20/200 that defines legal blindness. Read howstem cell transplants have restored vision We want to create a new class of devices with drastically improved … Continue reading

Posted in BioEngineering | Comments Off on Bioengineering to Restore Sight – Technology Networks

Grey's Anatomy Recap: #Japril Goes to Montana – Vulture

Posted: Published on March 17th, 2017

`,b;f~}>uzyQ61MP2.8|ToHw!]D~k+vvs?vc$0x67[~+?/x2EBd:6g[BL`7!,C? avkW5[]3~-Jbr>_&]#|]D'kE_U/q'h>";.wTrjK=>zKmM Sc$. |dST5+.QN&?zWK-;[ 19I2K!% !"Mlxr4c'~.f`:k:rZ'}Y,qq=Gb;#8HU 2|D,XQGzhaEo}1LZ^Dt|'FGl#|Kv9l#:m?R.0uAoA:K>m-7@W1yb1mCc#7=>FM@) !~7q1fk}q9O+YyswWw:5F{w U#x=,'m'5J/PiS|n9=MX/ OY"7krqQx3_|3~3tqIJ7l}y@[W"=:l $u%^"]V`|y~^z|W:;Gxi ] L-rAHSZcvJVx$r{gu"o9x%v3qyG>oo1-dy+wGJXrEqk _Iq]rSj?gLk/Cs30"9zQGezMGIPIpcK^Ho(M{5M%.S!Q=YIas/Qe5=[#:=hJt](fIts?w`6b5}2ci= V94>_?L(#Jm^~5X9fWmuwsJcv"wxC;QEF?}x.y|NopJ~s|{G JJ3w/Au.WZ+ssL-FO~R,hpfbKpC%z0Lau2c!:M>6=|SK=K93y+q~=A%WLw# g827l9'=zRB*>3pL[qO0S3iEw]CO+ %r@`DUf|]M]1M|e~kn wD0K,Z:wSz :^q;N?^u3&[|sH+h7+Va_$${*I"H5i1]iR|KpGU4zeRyFg-%0dY* 'IqA)Y{a|DwyrDxsf,!_7-KT*NPuz,[j4NXg&S}]$k WR_g7uf B(*drQw7a8/S!.RTG~%o-_tGGy#|v4H"N~O7 }r#(`*4>NJU!x!}I{JrV6(nU/!ty'#kkKqx[L ]W"C7h.WC"jO?.B`[ZSU*l4dDgr+[9(?z8o86xXx@AQ#ah+ZXnT]2G/({]epB?KmlJ,V(y*of[.C!GGAu;wz/Sv@8yOU||5c8"l$o/Yy{x8A.w*P@/weZn:SLUc+~fc^}5[u3 &8c' gElBkS,.X-E@ewfx{HMcckR;=V6BCg # O/&aXg_/dDgdM4F*9e7`8MVyJ=iP=:R%~|L,|*:rEaZ4-T0-8tn{tx?0]Q0 ZAD)>xDP0r[qv5Ca= =DN!~'Tusk:nC.E:oEOL"$,L5,@$DA+|UD^x7~ iN#E1yGr"_[=LqoAuct@vcpw-(4"EX3]d#:]tL~ $'':6w]F?db* E~o3(/9 ZL =4]}HI^()LJX#uR+w|+5xKGi XU=]ORrkGs;0Q"Y?6K3=0EO]z9POGL{P;z=k7go6Q8*/+?w'sM ~7>ZU:e| gP@iQr2dQT~fOq>5x9z )y8mkzOF KJp,pujwgzSq]y.8ZH)nQ?dGvh$~4o}|2LyP6x`|wQ(m9f: -a?j ,f/ll(EJ`!zUL^em=PK&45vZh^7tN%A=')A1FJ?3-xfJu|6gR$,!Cnu(>u]6+l#(({]z`0NLgzs+,=, a,dlJun Bu_MKF92mq598WyPQD&.aZx1~w5{^jB|qea6c9>=fytW % ^1JiBy5s! bv31qez?#|K g@Cj0kFz%lT` !5*zvUJI]Esfkb=Yc`9z7R,'s4soifg Il!iY!/6)MM3tRMW^->9TJbdZpz'DGwgNA{:8pRj8Dtd"9aE~a1.~kr@mV^/xao8NKftX|I9V|*x P{E_m9k{p )nxG =.@"|42w1v0s>-cXV7_8+dy^DjF^"vph@'xUNxJk0~ G] .(0r75~9a^EN{_%TVv~^z $,o9z3g|rI4 Kv9CE&>-nS L1BwrqiP+hk LZ;3ct~2 d81@24|KN=MuGFZsXa+2]otp^ +q7Y=v=` XXt!qg[HsY2ZzntJAw+;s91]o"&pgbD'f@_`?PC48oF,?8T m1@[6JXxDmO>?Yr'J&bJ VnLio?!BHX)]/h]N>eR9@gCpn:iqG.1QL0R ]r dXRs8.5g6KoP)S6h1d;oQQ;IK-QmbD. ~{~6ah{;/%#_|hk@FE B[.{0-_nXS9w=$3J`Z"tD"G3.uRAY*E8Ko!pa4vGs*b6~o::{xv,A *>S ebthY@tQ5sbN]{C owg#r{%)Z&D:[zoo'5~YEh(u"h15qp>%?:([ VH2aOF;6KL9_e^em*gKh*AI^3, 4RQjo(RrJPiPk~:J99r28q=q-%(BByCL;+!hn#0.#?UzO WnDH)S{ i^y}vLFpSu(qB_rO0B%L2N t`4JC,*zh$w' /2v^6|KdMnPlv8c?l~l,.F"E' T*+~w!c E3w'kX44K7>cEYlSYUw``^{y//W~W@*=Sg]u:))a;a{ _IH_}d4V3JGt}0a$&Cq-C89 =[(eM>>'d$iLiWL]y.wA >wjrSENYDaVxo%+I2F8i2D wj[pwk0>D;'2rn 1'JWr39 O7^J,O# G /sX3u@,./84s|_NC?tDtSKwD"gKT((p2?_4"GO5XXcm* W`y{>Fu,D6>Z[9 m 05$mb9WEQe1cW3wW:XCp2*ngoUvdP=8=rYWu"g3'=LK"`RIO%l|^0}wsM=yw7Ura`SzADBeQ9~$c2=>u7WCc"Lm07dD% )huu+}QDN8FuZ06IZu;*C0j;CKKPM$QCF*F]hl^ r` RqC2E"uN&IV4uhRtotb?0w2rkCpvT*N{NAD"MwIZwH"2gfr[5]/)z?|g=#H88MWW zx;IS^ |BJu|9kRB_Rs4y'V7*H8dF&rZk3]{ (AC72nN2tOd|b9u|]7?.B"Ja? g5w|+TR]+L&u 1LJ84&T 7GXh'dOo/8po;`mt?qbZNG.;[?K4,4d@8ah}3{^~QAs`2GPC!!cEf+GDlA3uQp*$@8.!fM@bO, 4;?ys_R/:tvAx[>Wn/g |"JBTsNZ|i@}G4jTC=4PNcd>$-:xUj~|R9P7F4K9T{ CR3}#HO"Y terr7}D^:'z.x@>yW?3:hpgRw 69/Vq(=RhrBJy|d@rS|NC* R5M^{ J5 $VXU|mPVa}%BC 7(BJqvE t /@ y'-sFnOs1P7Ek]t,R{(ss!OnSTO06mOM;;]Di&9wUI= i4qpx~cwdC&zveLv~[|A#eleJJ~ tx]))V;p9K6K36Z}?8W{3 (T S4WYsc'xM0>9 8~_ '8NQFQwxq? @ BYau4Sa/O:2>Tg!Y{f8j{MNlTZR>}[Y^(?/vW_m/+#^7M/&.i4;>MoqxIv"%?o?1e=!OX.?%yA GKa{ cDOo?PNziwJj?O~,ur _7{/l?}%AwmVJt/%D-)5x/pYR{!x-XHjz2x0#T(@e)7uPq;b:_u(|.GpTT| 87xs2C)_:C]WjZ+% m?Z OXwEkC{*B~Rln"P0QQ!zdt&OU *>dofwX:=W+YYfTENBe U~W&nOqJf+KRc%`B)pLV #dM16"k4#.";pb }1ctL:M?4ZiIO?W0v$q?Jm|VgCdQ6BN$@!svl{heY59u" 7a2 J/8:BjWPm]jVFI%l )8ts3C_26r'UI^"CO&r [ sC~Jxk H{u3~-:, UiN(&NE5,a}ikk]`}*S^ fzJ#/bb!= J4PC@X&S$Mf9t:k>H+PuK:V@>x _5/MNU|B{@GN%,lNGl1aG73qs7c-j6"hsg>~-O`L^"ya^7j !>iUb| _vl^JF;7Gl.~r=WIM7VR&'fQ d``HKHyJ4x}Ox7EK1~{@x~59i ^2+$0%mzZ(MfNH`w=EW5%~l C[vszG|OuXQNgN+3[Y}kpOqU/?iVR5OwW3?T;69m6y]}?(_1 xl d@"fjR+I'S}T_yY$B=Z4^*{B!c,]07sF:,DNtVsfN2O$G#x=q, ?X>C/$1N%uDPa R@I= 9aPUKT8DK}{#}WWa'i8DP@I]885vGp%H#|O]Nf&*NBA9& e>8&zMa]7#|#9'U~awF}4~U*c[V.7|;,gpv.o^ g'iCGR~nwRKP:w"0mO#YY)P"O.Fsy!8P(^:flu{L m)|,T]Fv!1l@Igt[wT"P*EFxL2?'>S=eqFNJ,}@4|S3P!{o#v`xz]B^~NQ:=?.'Cl`h7fg@Y4j ,BE(Txz>_~[6|0Mc}~#vB0`-]CI+uqRInS(w"JY^Gitc?rB~ xn03Zy?S}Nr[>i8Zn> =@>:|&B+)lyfj|S;j(k5jiqN~(3Dr|t4S"gBTW>y^6|vN;|'e1sD2WuL88M4;*zl/{{~ueP]X^;u0HFu/[& TtsGp)t{rgi2?8R3z0*%}>h:&{2I{V.f>C4k })ul+0^&MuHb@j*S_NupRvwjvs^n4e(n.>`6h|7?[{y:$ibX*U~BXMEU1tk__Etn2np?TG~SZrfvyEKRcC' -BQOg nhwCO{{?=?H981k*1m69 E6 8, lQu^wM={kNz~|/gQwJIBKhVZlpO[VJFSA%=?=v+ACDsJ|n(nA+5  3T7Hmy}"w11CGzsFNm|3elJ u~$Fz)D!,EIbU Xx^g4n=Z'])QKn@~$R|);:B'=_BMhi?&e}F:5rhjaIER24pth"vb1MPw[xOhA5#k 2Z;^)""-LSfHW[l84ke8k;-q0cl=Xmh``#a^Sj+]oT>=a~hr]N#nb[ E&gI+%?|T:a[FZgMedW(KoJ(rwS:ho6Y~Z5qq $"*^v~qYdoJe{+%UvG[ y`=#yt["s_+JrgEpUuedSn:dx6>X3k)sDh Yv8a;p!&ro:{#"VoV+o}xyy~:O8>`[ 'iZ` Ay}m8Mjnff;mR t..W`dCik`AszWE}m_e;s 4VP888fKD#vwE-pNvX oJ ?bN..b}UNrq"+c`O[C/u$ zT7exRC DOtK?*I'(67]$EMv7B%yub|;^sT-FjS>K]F>QZSJP!f Ju 8J#G}pe6=sVCXw1WW;e^`=G0MZg={haR +i_;LG,gGiF3qyvD}rHfl>qz$i{p!ENP=XgUG~+S`>#.(``vI%cKetT*Xrz'*Dgpx[A!v1rB^c.{s(=tWFq/m?g>>9a4)k^FgsD/bH+r&t9=8'rE: #Dkx#:A7QSH;6->k+/TRI)yO+?M^t2i'4&>!=}CO;f]/CF%=&&snB&Fhs? SYOM2Yg6R+B@t5D .ee0qw$7s[+K8K`]h39bg1oZa[^bDmAZUka{/&w3C= l&02*+=fgm(+Sjv-H}>8)Jr5!YU pt2oG2j|u0wDu!x ?N*T&t!$4X#i(*`f{,Q-{wv}6O%5gpi=00a#U=v!3x ,2+G)V]VvoGO&+uvD#p~@ d]HEyek'@xxUU#G;6b Dn-wp#*T3tZ1f^gA |vO,dy$bZ2?FD2$(e oyhx uEL"LXAIg2}~t!%^_5RGDXm`2'0Qz35{&k[iU%FQ@?~%X/ipgr=O-BD.FlnD}GKV'K@-Qii/uW6W=AdY:>J utgi>6>E[]P:7'-sRRSkVJhc;A1|^#!,PsFP;,>|hIoyYO_&-3q{:P5rCfxS#2Dx#f KLPN.P9'Jh{]UqQIqjb (v>L;V`h6&w|F_Gcw%n#Wg?:~L-{~/q7`~~iZrKWN $ejK5g(;gGx%L[xv /:N*zxmpKi{vuS|Q~WRvAM@kR9^K/>_g!VA%/R{l|Vh-&$/Gt*tw)aZIj'@{jp)H;u[:u94i0sGpsD#QTe … Continue reading

Posted in Anatomy | Comments Off on Grey's Anatomy Recap: #Japril Goes to Montana – Vulture

'Grey's Anatomy' Star Sara Ramirez Has Something To Say About Bi-Erasure – Huffington Post

Posted: Published on March 17th, 2017

Sara Ramirez is speaking out about what she sees as bi-erasure in When We Rise, Dustin Lance Blacks new mini-series about the LGBT movement. Ramirez took to Twitter earlier this week to share her thoughts on the exclusion of bisexual pioneers from the mini-seriesnarrative, which premiered last month. She tweeted a quote card featuring the words of bisexual advocate and founder of the bisexual political action group BiPOL, Lani Kaahumanu. Kaahumanus words were included in a recent blog post by Martin Rawlings-Fein, which discussed the implication of the exclusion of bisexualsin When We Rise. [T]he truth is that we have been telling our stories separately for years and being told to shut up because nobody in the gay community wants to hear them, he wrote. Our stories are not convenient, they do not fit into the boxes in which others try to place them. Black responded to Ramirezs tweet, saying that bisexuals are included in his series, but they simply did not define themselves with such a label at the time. As for Ramirez, she is ready to work with Black to help get bi stories told. The Greys Anatomy star came out as a queer bisexual woman last year … Continue reading

Posted in Anatomy | Comments Off on 'Grey's Anatomy' Star Sara Ramirez Has Something To Say About Bi-Erasure – Huffington Post

Makeshift Syrian rehab center offers hope to paralyzed – AOL

Posted: Published on March 17th, 2017

27 PHOTOS Makeshift shelter offers help to paralyzed war victims See Gallery Abu Yassin, 47, attends a physiotherapy session at a spinal cord injury rehabilitation centre in Douma, the main rebel-stronghold in eastern Ghouta on the outskirts of Damascus, Syria, February 14, 2017. REUTERS/Bassam Khabieh SEARCH "SPINE" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES. Training equipments are seen at a spinal cord injury rehabilitation centre in Douma, the main rebel-stronghold in eastern Ghouta on the outskirts of Damascus, Syria, February 14, 2017. REUTERS/Bassam Khabieh SEARCH "SPINE" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES. Obeida, 18, a medic at a spinal cord injury rehabilitation centre, walks inside a patient's house to take him to the centre in Douma, the main rebel-stronghold in eastern Ghouta on the outskirts of Damascus, Syria, February 13, 2017. REUTERS/Bassam Khabieh SEARCH "SPINE" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES. Paraplegic Hussein (R), 35, gets help to go to a spinal cord injury rehabilitation centre in Douma, the main rebel-stronghold in eastern Ghouta on the outskirts of Damascus, Syria, February 13, 2017. REUTERS/Bassam Khabieh SEARCH "SPINE" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES. TPX IMAGES OF THE DAY Abu … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Makeshift Syrian rehab center offers hope to paralyzed – AOL

Neuralstem to Present at Oppenheimer 27th Annual Healthcare Conference on March 21 – EconoTimes

Posted: Published on March 17th, 2017

Neuralstem to Present at Oppenheimer 27th Annual Healthcare Conference on March 21 GERMANTOWN, Md., March 17, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, announces that Rich Daly, Chairman and CEO of Neuralstem, will present at the Oppenheimer27th Annual Healthcare Conference at The Westin New York Grand Central in New York. The presentation is scheduled for Tuesday, March 21, 2017 at 1:00 p.m. Eastern time. The live audio webcast of the presentation can be accessed here:Neuralstem. An archive of the presentation will be available approximately three hours after the live event and will be available for 90 days. About Neuralstem Neuralstems patented technology enables the commercial-scale production of multiple types of central nervous system stem cells, which are being developed as potential therapies for multiple central nervous system diseases and conditions. Neuralstems technology enables the discovery of small molecule compounds by systematic screening chemical compounds against its proprietary human hippocampal stem cell line. The screening process has led to the discovery and patenting of molecules that Neuralstem believes may stimulate the brains capacity to generate new neurons, potentially reversing pathophysiologies associated with certain central nervous … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Neuralstem to Present at Oppenheimer 27th Annual Healthcare Conference on March 21 – EconoTimes

UNF study of tiny brittle stars could help treat injuries in humans – Florida Times-Union

Posted: Published on March 17th, 2017

Dr. Vladimir Mashanov, UNF assistant professor of biology, studies organ regeneration in the group of marine invertebrates called echinoderms, which include sea cucumbers and brittle stars -- the two model organisms hes working with. Unlike humans, these animals can regrow almost any part of their body after injury, including major regions of their central nervous system. Even though modern echinoderms and humans dont look similar, they share common evolutionary ancestry. Therefore, there is a good chance that better understanding of the mechanisms that drive rapid post-traumatic regeneration in echinoderms will facilitate development of new, more efficient, therapeutic approaches to treat human injuries, for example, spinal cord injuries. On Tuesday March 14, 2017 Mashanov and one of his undergraduate students pointed out the regenerated growth on several brittle stars, specifically Ophioderma brevispinum, in the research lab on the University of North Florida campus in Jacksonville, Fl. | Buy Photos See original here: UNF study of tiny brittle stars could help treat injuries in humans - Florida Times-Union … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on UNF study of tiny brittle stars could help treat injuries in humans – Florida Times-Union

Are These 2 Biotechs Diamonds in the Rough? — The Motley Fool – Motley Fool

Posted: Published on March 17th, 2017

With literally hundreds of biotech and pharmaceutical stocks to choose from, most investors either buy the well-known names (Johnson & Johnson, Gilead, Merck) or an index (IBB, VHT). However, for the investor willing to go the extra mile, a little bit of digging often results in the discovery of diamonds in the rough. Two such potential gems in today's market are small cap biotech firms Adamas Pharmaceuticals (NASDAQ:ADMS) and Amicus Therapeutics (NASDAQ:FOLD) Adamas Pharmaceuticals is a small-cap pharmaceutical company focused on the development and commercialization of therapeutics targeting disorders of the central nervous system. Their lead product in development is ADS-5102, a product being studied for Levodopa-Induced Dyskinesia (LID) associated with Parkinson's disease. In December 2015 and April 2016, Adamas released positive data from two separate phase 3 studies of ADS-5102 for thetreatment of LID. Image source: Getty Images. Parkinson's disease is a life-threatening neurodegenerative illness characterized by a progressive decrease in patient motor functions. The disease impacts an estimated 1 million Americans. While the combination treatment of oral levodopa (LD) and carbidopa (CD) is considered the "gold-standard" in Parkinson's treatment, there are several shortcomings with this current method of care.Due to the nature of its oral administration, oral LD/CD … Continue reading

Posted in Parkinson's Treatment | Comments Off on Are These 2 Biotechs Diamonds in the Rough? — The Motley Fool – Motley Fool

To Go to Sleep, Parkinson’s Patients May Need to Turn the Light On – Medical News Bulletin

Posted: Published on March 17th, 2017

Sleep disturbance is one of the lesser-known but one of the most common symptoms in Parkinsons disease. Using light therapy shows promise in alleviating this, without the accompanying side-effects that medications bring. Most of us are aware of the obvious manifestations of Parkinsons disease (PD); we readily identify and associate the tremors or the slurring of speech as symptoms of Parkinsons. However, what is less known is that up to ninety percent of people who live with Parkinsons also suffer from sleep disorders. Patients with Parkinsons have no trouble going to sleep; however, something triggers them to awaken, or that keeps waking them up, disrupting their sleep cycle. Among the identified causes are the involuntary movements that continue even while sleeping which then jerk them awake; other patients on dopamine medication (the standard drug for PD) report experiencing recurring vivid nightmares that understandably makes patients uncomfortable about sleeping. Like those suffering from sleep disturbances, this leads to daytime somnolence or sleepiness in the morning and afternoons. We all know how bothersomeand potentially dangerouslack of sleep can be; impaired awareness and function increases the possibility of accidents when driving vehicles, or operating heavy machinery. When a person is afflicted with Parkinsons, … Continue reading

Posted in Parkinson's Treatment | Comments Off on To Go to Sleep, Parkinson’s Patients May Need to Turn the Light On – Medical News Bulletin

Patients, researchers share information about concussion injuries, treatment – The Columbus Dispatch

Posted: Published on March 17th, 2017

JoAnne Viviano The Columbus Dispatch @JoAnneViviano Rosemarie Bauer used to work nine hours a day at her online jewelry business. Today, she manages only about three hours a week. Everything changed in October, when the 62-year-old suffered a brain injury after being hit from behind by an SUV while walking her dog in her New Albany neighborhood. "I am still on my journey back," she said. "I still have sensitivity to light and sound, my sense of taste is not good. I still have occasional dizziness, I sometimes have unprovoked crying and sadness, I cannot drive. I sometimes question myself." Bauer shared her story this week at the Ohio Concussion Summit, which was sponsored by the OhioHealth Rehabilitation Hospital and the Brian Injury Association of Ohio. The event, held at the Fawcett Center at Ohio State University, was attended by nurses, social workers, physical, occupational and speech therapists and others. John Corrigan, director of the Ohio Brian Injury Program, said 100,000 Ohioans suffer traumatic brain injuries each year and that 1.8 million adults in the state have had at least one traumatic brain injury causing unconsciousness. As many as 750,000, he said, are at risk of disability. At the summit, … Continue reading

Posted in Brain Injury Treatment | Comments Off on Patients, researchers share information about concussion injuries, treatment – The Columbus Dispatch

Page 1,897«..1020..1,8961,8971,8981,899..1,9101,920..»